Neimeth International Pharmaceuticals Plc. (the Company) wishes to inform Nigerian Exchange Limited (NGX) and the investing public that at the Board of Directors meeting of 28th July 2022, the Board approved the Unaudited Financial Statements for the period ended 30 June 2022 and same will be filed on or before the due date of 30th July 2022, and thereafter, the closed period earlier announced will be lifted.
Visit Neimeth International Pharmaceuticals Plc IR Page in Proshare MARKETS